Vivek Mehta, M.D., is a radiation oncologist at Swedish Cancer Institute, Seattle, and a new member of the ITN Editorial Advisory Board.


Radiation oncology is an important area of concentration for Imaging Technology News (ITN), as we provide coverage of radiation therapy technology, treatment planning solutions and data management systems specifically for radiation oncology.

As we strive to further strengthen our expertise in this field, I am honored to welcome Vivek Mehta, M.D., a radiation oncologist at Swedish Cancer Institute, Seattle, to the ITN Editorial Advisory Board.
Dr. Mehta joined Swedish Cancer Institute in 2002, and is actively involved in designing and developing clinical research studies at Swedish Cancer Institute and through national research organizations, including the Southwestern Oncology Group.

His clinical interests include image-guided radiotherapy, balloon catheter-based breast brachytherapy, gamma knife radiosurgery, intensity modulated radiotherapy, stereotactic radiosurgery, and three-dimensional conformal radiotherapy.

Dr. Mehta has been involved in a number of clinical research studies and has been widely published in medical journals and publications. He has written several articles evaluating the use of concurrent chemotherapy and radiation in the management of malignancy, which he also presented at national and international meetings. His research has appeared in the peer-reviewed International Journal of Radiation Oncology, Biology and Physics, the American Journal of Clinical Oncology, Archives of Surgery, and the Journal of Gastrointestinal Surgery.

A graduate of Georgetown University, Dr. Mehta earned his medical degree from the University of Washington and completed his internship at both the Legacy Good Samaritan Medical Center and Legacy Emanuel Hospital in Portland, Ore. He completed his residency at Stanford University Medical, where he also served as chief resident in the radiation oncology department. He is board certified in therapeutic radiology.

In 2004 and 2006, Seattle magazine named Dr. Mehta one of the city’s top doctors in the area of radiation oncology. Other accolades include numerous resident/fellow research awards, such as the Malcolm A. Bagshaw Radiation Oncology Resident Award. He is the current scientific program chair for the Washington State Radiation Oncology Society and is also active in the American Society of Therapeutic Radiation Oncologists, the American College of Radiology and the American Association of Indian Physicians, and the American Society of Clinical Oncology.
In addition to his work at the Swedish Cancer Institute, Dr. Mehta is an assistant clinical professor at the University of Washington School of Medicine. To contact Dr. Mehta, e-mail him at: [email protected]


Related Content

News | Radiation Therapy

April 18, 2024 — Accuray Incorporated announced that as part of its commitment to advancing patient care the company has ...

Time April 18, 2024
arrow
News | FDA

April 18, 2024 — Lumicell, Inc., a privately held company focused on developing innovative fluorescence-guided imaging ...

Time April 18, 2024
arrow
News | Lung Imaging

April 17, 2024 — A Medicare policy requiring primary care providers (PCPs) to share in the decision-making with patients ...

Time April 17, 2024
arrow
News | Mammography

April 16, 2024 — The Radiological Society of North America (RSNA) and GE HealthCare announced their collaboration to ...

Time April 16, 2024
arrow
News | Clinical Trials

April 16, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time April 16, 2024
arrow
Videos | Breast Imaging

Don't miss ITN's latest "One on One" video interview with AAWR Past President and American College of Radiology (ACR) ...

Time April 15, 2024
arrow
News | Mammography

April 12, 2024 — Bayer and Hologic, Inc. announced a first-of-its-kind collaboration to deliver a coordinated solution ...

Time April 12, 2024
arrow
News | Mammography

April 12, 2024 — GE HealthCare, a leader in breast health technology and diagnostics, will feature its latest breast ...

Time April 12, 2024
arrow
News | Radiation Therapy

April 12, 2024 — RTsafe, a leading provider of quality assurance products and services in stereotactic radiosurgery, and ...

Time April 12, 2024
arrow
News | Radiation Dose Management

April 11, 2024 — Prelude Corporation (PreludeDx), a leader in precision diagnostics for early-stage breast cancer ...

Time April 11, 2024
arrow
Subscribe Now